ZT-1 for the symptomatic treatment of mild to moderate Alzheimer disease (AD): Preliminary results of a multicenter, randomised, double-blind, placebo and active controlled phase II study
Tamchès E, Orgogozo JM, Wilkinson D, Yancheva ST, Gagiano C, Grosgurin P, Porchet H, Scalfaro P, 2006. pp. S625 dans Alzheimer's Association 10th International Conference on Alzheimer's Disease and Related Disorders, Alzheimer's & Dementia.
ici le détail